Search results
Results from the WOW.Com Content Network
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112(a).
AMGen corporate logo, 1983 Argentine president Mauricio Macri meets with heads of Amgen, in 2018. Amgen was established in Thousand Oaks in 1980, as Applied Molecular Genetics. [6] [7] Amgen was backed by a small group of venture capitalists, and its early focus was on recombinant DNA technology and recombinant human insulin. [8]
For premium support please call: 800-290-4726 more ways to reach us
In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013. [5] During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 [8] to $26 billion in 2021, [9] and annual R&D investment increased to $4.2 billion in 2020. [10]
Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its ... Lilly recorded a total of $2 billion from its GLP-1 products in 2023, while Novo Nordisk pocketed ...
A while back, I argued that Amgen still had room to run based on its strong pipeline, financial position, and comparative valuation. The acquisition of Onyx was a major step in accomplishing those ...
The Tour of California (officially sponsored as the Amgen Tour of California) was an annual professional road cycling stage race on the UCI World Tour and USA Cycling Professional Tour that ran from 2006 to 2019. It was the only event on the top-level World Tour in the United States.